V. Rijckborst Et Al. , "Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a," JOURNAL OF HEPATOLOGY , vol.56, no.5, pp.1006-1011, 2012
Rijckborst, V. Et Al. 2012. Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a. JOURNAL OF HEPATOLOGY , vol.56, no.5 , 1006-1011.
Rijckborst, V., Hansen, B. E., Ferenci, P., Brunetto, M. R., Tabak, F., Cakaloglu, Y., ... Lanza, A. G.(2012). Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a. JOURNAL OF HEPATOLOGY , vol.56, no.5, 1006-1011.
Rijckborst, Vincent Et Al. "Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a," JOURNAL OF HEPATOLOGY , vol.56, no.5, 1006-1011, 2012
Rijckborst, Vincent Et Al. "Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a." JOURNAL OF HEPATOLOGY , vol.56, no.5, pp.1006-1011, 2012
Rijckborst, V. Et Al. (2012) . "Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a." JOURNAL OF HEPATOLOGY , vol.56, no.5, pp.1006-1011.
@article{article, author={Vincent Rijckborst Et Al. }, title={Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a}, journal={JOURNAL OF HEPATOLOGY}, year=2012, pages={1006-1011} }